Rab22a is a novel prognostic marker for cell progression in breast cancer.
He M, Shen L, Jiang C, Gao G, Wang K, Jiao Y, Sun L, Cui Y, Ke Z, Yang Z.
He M, et al. Among authors: jiang c.
Int J Mol Med. 2020 Apr;45(4):1037-1046. doi: 10.3892/ijmm.2020.4486. Epub 2020 Feb 5.
Int J Mol Med. 2020.
PMID: 32124943
Free PMC article.
Clinical Trial.